BIOMAT Database Logo BIOMAT Database Logo

Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities. 2005

Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143-2280, USA.

A simple two-step synthesis method was used to make 51 B-ring-substituted 4-hydroxyquinolines allowing analysis of the effect of ring substitutions on inhibition of growth of chloroquine sensitive and resistant strains of Plasmodium falciparum, the dominant cause of malaria morbidity. Substituted quinoline rings other than the 7-chloroquinoline ring found in chloroquine were found to have significant activity against the drug-resistant strain of P. falciparum W2.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D000634 Aminoquinolines Quinolines substituted in any position by one or more amino groups.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
A synthesis of substituted 4-aminoquinolines.
July 1946, Journal of the American Chemical Society,
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
Antimalarial activities of ring-substituted bioimidazoles.
July 2002, Bioorganic & medicinal chemistry letters,
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
Antimalarial agents. 8. Ring-substituted bis(4-aminophenyl) sulfones and their precursors.
December 1971, Journal of medicinal chemistry,
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
Synthesis, cytotoxicity and antimalarial activity of ferrocenyl amides of 4-aminoquinolines.
January 2010, Arzneimittel-Forschung,
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
Three 4-aminoquinolines of antimalarial interest.
February 2006, Acta crystallographica. Section C, Crystal structure communications,
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
1,2-substituted 4-(1H)-quinolones: synthesis, antimalarial and antitrypanosomal activities in vitro.
September 2014, Molecules (Basel, Switzerland),
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
[Synthesis of substituted 4-styrylcoumarin and their antitumor activities].
April 2001, Yao xue xue bao = Acta pharmaceutica Sinica,
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
Synthesis of new 4-aminoquinolines and quinoline-acridine hybrids as antimalarial agents.
December 2010, Bioorganic & medicinal chemistry letters,
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
Substituted 1,3-dioxoisoindoline-4-aminoquinolines coupled via amide linkers: Synthesis, antiplasmodial and cytotoxic evaluation.
July 2019, Bioorganic chemistry,
Peter B Madrid, and John Sherrill, and Ally P Liou, and Jennifer L Weisman, and Joseph L Derisi, and R Kiplin Guy
[Synthesis of 4-methyl-5-substituted phenoxy-primaquine analogues and preliminary evaluation on their antimalarial activity].
January 1994, Yao xue xue bao = Acta pharmaceutica Sinica,
Copied contents to your clipboard!